Dual Targeting Biomimetic Carrier‐Free Nanosystems for Photo‐Chemotherapy of Rheumatoid Arthritis via Macrophage Apoptosis and Re‐Polarization
Advanced Science · 2025-03 · 12 (10)
DOI: 10.1002/advs.202406877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.01.2025. Verfasst von Guanghe Xue und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266071, China. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Apoptosis, Methotrexate, Macrophages. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province, Taishan Scholar Foundation of Shandong Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a common chronic systemic autoimmune disease that often results in irreversible joint erosion and disability. Methotrexate (MTX) is the first‐line drug against RA, but the significant side effects of long‐term administration limit its use. Therefore, new therapeutic strategies are needed for treating RA. Here, dual‐targeting biomimetic carrier‐free nanomaterials (BSA‐MTX‐CyI nanosystem, BMC) is developed for synergistic photo‐chemotherapy of RA. Bovine serum albumin (BSA), which has high affinity with SPARC (secreted protein acidic and rich in cysteine) in the RA joint microenvironment, is selected as the hydrophilic end and coupled with MTX and the phototherapeutic agent CyI to self‐assemble into BMC. In vitro and in vivo experiments revealed that BMC accumulated significantly at the joint site in collagen antibody‐induced arthritis mice and could be specifically recognized and taken up by folate receptors in proinflammatory M1 macrophages. Upon near‐infrared laser irradiation, CyI exerted photodynamic and photothermal effects, whereas MTX not only inhibited cell proliferation but also increased cell sensitivity to reactive oxygen species, enhancing the apoptotic effect induced by CyI and achieving synergistic photo‐chemotherapy. Moreover, BMC could induce macrophages to reprogram into anti‐inflammatory M2 macrophages. This study provides innovative approaches for RA treatment via macrophage apoptosis and re‐polarization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266071, China.
- Department of Pharmacology, School of Pharmacy, Qingdao University, Qingdao, 266071, China.
- Department of Radiation Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266000, China.
ORCID-Profile: Jie Cao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shandong Province
- Taishan Scholar Foundation of Shandong Province
Zitieren
APA
Xue, G., Jiang, H., Song, Z., Zhao, Y., Gao, W., Lv, B., & Cao, J. (2025). Dual Targeting Biomimetic Carrier‐Free Nanosystems for Photo‐Chemotherapy of Rheumatoid Arthritis via Macrophage Apoptosis and Re‐Polarization. Advanced Science, 12(10). https://doi.org/10.1002/advs.202406877
Vancouver
Xue G, Jiang H, Song Z, Zhao Y, Gao W, Lv B, et al. Dual Targeting Biomimetic Carrier‐Free Nanosystems for Photo‐Chemotherapy of Rheumatoid Arthritis via Macrophage Apoptosis and Re‐Polarization. Advanced Science. 2025;12(10). doi:10.1002/advs.202406877
BibTeX
@article{Xue2025,
author = {Xue, Guanghe and Jiang, Huimei and Song, Zhenhua and Zhao, Yifan and Gao, Wen and Lv, Bai and Cao, Jie},
title = {Dual Targeting Biomimetic Carrier‐Free Nanosystems for Photo‐Chemotherapy of Rheumatoid Arthritis via Macrophage Apoptosis and Re‐Polarization},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {10},
doi = {10.1002/advs.202406877}
}
EUVIMED